Navigation Links
BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients
Date:4/26/2008

that can cause AIDS) and are not taking medicines for HIV at the same time, some HIV treatments that they may take in the future may be less likely to work. People are advised to get an HIV test before starting to take BARACLUDE and anytime that there is a chance they were exposed to HIV. BARACLUDE will not help HIV infection.

In some people, hepatitis B symptoms may get worse or become very serious when they stop taking BARACLUDE. People should not stop BARACLUDE without talking to their healthcare provider. Healthcare providers will need to follow their patients and do blood tests to check the liver when BARACLUDE is stopped. People should tell their healthcare provider if they have or develop kidney problems because their healthcare provider may want to do tests to see if a lower dose is needed.

Because BARACLUDE is removed from the body through the kidneys, a dose adjustment may be required. Healthcare providers may want to perform tests to determine whether a patient needs a lower dose or should take BARACLUDE less often than once a day.

It is not known if BARACLUDE(R) (entecavir) is safe to use during pregnancy. It is not known if BARACLUDE helps to prevent a pregnant mother from passing HBV to her baby. A pregnant woman and her healthcare provider will need to decide if BARACLUDE is right for her. A woman should not breastfeed if she is taking BARACLUDE.

People should discuss with their healthcare provider all prescription and non-prescription medicines, vitamins, herbal supplements, and other health preparations they are taking or plan to take. BARACLUDE may interact with medicines that leave the body through the kidneys. The safety and effectiveness of BARACLUDE in liver transplant recipients is unknown. The most common side effects of BARACLUDE in clinical studies were headache, tiredness, dizziness, and nausea.

This list of side effects is not complete at this time because BARACLUDE is still under study. People should re
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
9. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
10. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
11. Many Heart Attack Patients Dont Get Best Emergency Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2008)...EAPOLIS, July 22 /- Nonin Medical, a ...tions for more than 20 years, has entered,the clin...y to measure,regional oxygen saturation. Today,s m...continuous monitoring of the regional blood oxygen...esting data and outcomes from an ongoing clinical ...
(Date:7/22/2008)...DA Meeting to Discuss Development Plan Completed S...-FirstCall/ -- Amarin Corporation,plc (NASDAQ: AM... with,officials at the U.S. Food and Drug Administ...elop AMR101 for the treatment of,hypertriglyceride...roceeding to Phase 3 with AMR101 in hypertriglycer...
(Date:7/22/2008)...-of-the-Art PET Study Confirms Tyrima Exhibits Exc...erties - - Results Support Initiation of Pha...N.C., July 22 /- CeNeRx BioPharma,In...cializing innovative,treatments for diseases of th... advance its lead candidate Tyrima(TM) into Phase ...
(Date:7/22/2008)...eoffrey Allan Will Stress the Importance to Patien...cs Approval Pathway, RICHMOND, Va., July 22 /PRNe... a developer of follow-on biologics and biopharmac...D., CEO of Insmed, will present at a,Congressional...e,significant need for establishing an approval pa...
Breaking Medicine Technology:Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Serum sodium predicts mortality 10 times higher in PAH patients 21781 1Serum sodium predicts mortality 10 times higher in PAH patients 21781 2New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 1New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 2New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 3New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 4New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 5New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 6New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 71 in 8 Lower Manhattan residents had signs of PTSD 2 to 3 years after 9 11 21776 11 in 8 Lower Manhattan residents had signs of PTSD 2 to 3 years after 9 11 21776 2Membrane complexes take flight 5975 1Membrane complexes take flight 5975 2
(Date:7/25/2008)... firm represents Pickerington man who contracted E... Kroger store , Columbus,...onaheyohioinjurylawyers.com [The Donahey Law Firm... central Ohio, has filed a product liability lawsu...ainst The Kroger Co., in connection with an E. col...
(Date:7/24/2008)...ital facility on Sand Canyon Avenue , ...08 -- Hoag Memorial Hospital Presbyterian has reac...l Estate Investment Trust headquartered in Long Be... Sand Canyon Avenue near the 405 freeway in Irvine...d by Tenet Healthcare Corporation (NYSE: THC) as I...
(Date:7/24/2008)...stCall/ -- ev3 Inc. (Nasdaq:,EVVV) today announced...and,year-to-date financial results. ev3 will now r...ancial results on Monday, July 28, 2008, after reg... a conference call and webcast at 7:30 a.m.,Centra...9, 2008. ev3,management will review its second qua...
(Date:7/24/2008)...ine Annual Report Experience it at http:/...f., July 24 /PRNewswire/ -- Are you an e-patient?,...users go online for,health information. Thanks to ...re personal health experiences, shop for health ca...Go to http://SutterHealth.org/annualreport ,and y...
Breaking Medicine News(10 mins):Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2Health News:ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call 2Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 2Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 3Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 4
...edouble its efforts in the fight against HIV and A...tions program on HIV/AIDS, comes after Fiji's Mini...e in the number of people living with HIV and AIDS... The figures show that there were 36 new cases in...
...zil, Paraguay and Bolivia after an outbreak of den...fall //this season as a cause of the unusually rap...ncommonly warm weather has boosted the population ...the disease. Globally, it infects 50 million peo...
...Ministry of Health reported 789 suspected cases in...he country. // Ouargaye district has an attack rat...istricts, Banfora, Batie and Sapouy are in the ale...specimens have tested positive for Neisseria menin...
...als in the brain of mice were augmented, condition...ate in such animals. //This was reported by resear...alifornia. This finding could throw light in the ...cording to this study published in Nature, a combi...
Other Medicine News:
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
...w Binding, Graduated Pipet Tips - 0.5l - 10 L. Des... and protein binding. Non-reactive. Beveled and re...tion. RNAse & DNAse free. AVR100S is the Sterile R...0 is the Cell Rack packaged 96 tips/rack and 10 ra...
Packed conveniently in plastic-wrapped racks of 96 tips, Sterilized Diamond- Tips are ready to useno need to autoclave. Sterilized Diamond Tips are irradiated by gamma-rays for more efficient sterili
Like all Gilson disposable pipette tips, TowerPacks are available in a sterilized version. Each Sterilized TowerPack is individually wrapped in medical device-quality plastic to help protect tips fro
Medicine Products: